Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis

Background & Aims Steatosis is a prominent feature of hepatitis C, especially in patients infected with genotype 3. The analysis of genetic polymorphisms influencing steatosis in chronic hepatitis C has been limited by the studies’ small sample size, and important single nucleotide polymorphisms...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2011-09, Vol.55 (3), p.529-535
Hauptverfasser: Cai, Tao, Dufour, Jean-François, Muellhaupt, Beat, Gerlach, Tilman, Heim, Markus, Moradpour, Darius, Cerny, Andreas, Malinverni, Raffaele, Kaddai, Vincent, Bochud, Murielle, Negro, Francesco, Bochud, Pierre-Yves
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background & Aims Steatosis is a prominent feature of hepatitis C, especially in patients infected with genotype 3. The analysis of genetic polymorphisms influencing steatosis in chronic hepatitis C has been limited by the studies’ small sample size, and important single nucleotide polymorphisms (SNPs), such as those in the patatin-like phospholipase family 3 protein ( PNPLA3 ), were never evaluated. Methods We analyzed the role of SNPs, from 19 systematically selected candidate genes, on steatosis in 626 Caucasian hepatitis C virus (HCV) infected patients. SNPs were extracted from a genome-wide association-generated dataset. Associations of alleles with the presence and/or different severity of steatosis were evaluated by univariate and multivariate logistic regression, accounting for all relevant covariates. Results The risk of steatosis was increased by carriage of I148 M in PNPLA3 , but only in patients with HCV genotypes non-3 (odds ratio [OR] = 1.9, 95% confidence interval [CI] = 1.6–2.3, p
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2010.12.020